{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:22:52Z","timestamp":1789708972932,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI160606"],"award-info":[{"award-number":["R21AI160606"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s10067-024-07074-4","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T12:03:18Z","timestamp":1721995398000},"page":"2765-2781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Infection prophylaxis among patients with antineutrophil cytoplasmic antibody (ANCA) vasculitis: a scoping review"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7142-7760","authenticated-orcid":false,"given":"Binxin","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob E.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Winget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison H.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal K.","family":"Derebail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn T.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"7074_CR1","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/annrheumdis-2016-210942","volume":"76","author":"JA Tan","year":"2017","unstructured":"Tan JA, Dehghan N, Chen W, Xie H, Esdaile JM, Avina-Zubieta JA (2017) Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies. Ann Rheum Dis 76:1566\u20131574","journal-title":"Ann Rheum Dis"},{"key":"7074_CR2","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G et al (2021) 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol 73:1366\u20131383","journal-title":"Arthritis Rheumatol"},{"key":"7074_CR3","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1093\/rheumatology\/keaa070","volume":"59","author":"SH Sarica","year":"2020","unstructured":"Sarica SH, Dhaun N, Sznajd J, Harvie J, McLaren J, McGeoch L et al (2020) Characterizing infection in anti-neutrophil cytoplasmic antibody-associated vasculitis: results from a longitudinal, matched-cohort data linkage study. Rheumatology (Oxford) 59:3014\u20133022","journal-title":"Rheumatology (Oxford)"},{"key":"7074_CR4","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3899\/jrheum.160909","volume":"44","author":"AJ Mohammad","year":"2017","unstructured":"Mohammad AJ, Segelmark M, Smith R, Englund M, Nilsson J-\u00c5, Westman K et al (2017) Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol 44:1468\u20131475","journal-title":"J Rheumatol"},{"key":"7074_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/acr.22976","volume":"69","author":"ZS Wallace","year":"2017","unstructured":"Wallace ZS, Lu N, Miloslavsky E, Unizony S, Stone JH, Choi HK (2017) Nationwide trends in hospitalizations and in-hospital mortality in granulomatosis with polyangiitis (Wegener\u2019s). Arthritis Care Res (Hoboken) 69:915\u2013921","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7074_CR6","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/ard.2009.109389","volume":"69","author":"MA Little","year":"2010","unstructured":"Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C et al (2010) Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69:1036\u20131043","journal-title":"Ann Rheum Dis"},{"key":"7074_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12882-018-1102-3","volume":"19","author":"D Titeca-Beauport","year":"2018","unstructured":"Titeca-Beauport D, Francois A, Lobbedez T, Guerrot D, Launay D, Vrigneaud L et al (2018) Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre study. BMC Nephrol 19:317","journal-title":"BMC Nephrol"},{"key":"7074_CR8","doi-asserted-by":"publisher","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC et al (2023) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2022-223764","DOI":"10.1136\/ard-2022-223764"},{"key":"7074_CR9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.lpm.2013.08.003","volume":"42","author":"P Charles","year":"2013","unstructured":"Charles P, Bienvenu B, Bonnotte B, Gobert P, Godmer P, Hachulla \u00c9 et al (2013) Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides. Presse Med 42:1317\u20131330","journal-title":"Presse Med"},{"key":"7074_CR10","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","volume":"53","author":"E Ntatsaki","year":"2014","unstructured":"Ntatsaki E, Carruthers D, Chakravarty K, D\u2019Cruz D, Harper L, Jayne D et al (2014) BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford) 53:2306\u20132309","journal-title":"Rheumatology (Oxford)"},{"key":"7074_CR11","doi-asserted-by":"crossref","unstructured":"Souza AWS de, Calich AL, Mariz H de A, Ochtrop MLG, Bacchiega ABS, Ferreira GA et al (2017) Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis. Rev Bras Reumatol 57(Suppl 2):484\u2013496","DOI":"10.1016\/j.rbre.2017.06.003"},{"key":"7074_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3899\/jrheum.200721","volume":"48","author":"A Mendel","year":"2021","unstructured":"Mendel A, Ennis D, Go E, Bakowsky V, Baldwin C, Benseler SM et al (2021) CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update. J Rheumatol 48:555\u2013566","journal-title":"J Rheumatol"},{"key":"7074_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/eci.12410","volume":"45","author":"A Kronbichler","year":"2015","unstructured":"Kronbichler A, Jayne DRW, Mayer G (2015) Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis. Eur J Clin Invest 45:346\u2013368","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 1","key":"7074_CR14","doi-asserted-by":"publisher","first-page":"i171","DOI":"10.1093\/ndt\/gfv045","volume":"30","author":"JG McGregor","year":"2015","unstructured":"McGregor JG, Negrete-Lopez R, Poulton CJ, Kidd JM, Katsanos SL, Goetz L et al (2015) Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function. Nephrol Dial Transplant 30(Suppl 1):i171\u2013i181","journal-title":"Nephrol Dial Transplant"},{"key":"7074_CR15","doi-asserted-by":"publisher","first-page":"102505","DOI":"10.1016\/j.autrev.2020.102505","volume":"19","author":"C Thery-Casari","year":"2020","unstructured":"Thery-Casari C, Euvrard R, Mainbourg S, Durupt S, Reynaud Q, Durieu I et al (2020) Severe infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides receiving rituximab: a meta-analysis. Autoimmun Rev 19:102505","journal-title":"Autoimmun Rev"},{"key":"7074_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/ard.2008.088302","volume":"68","author":"C Charlier","year":"2009","unstructured":"Charlier C, Henegar C, Launay O, Pagnoux C, Berezn\u00e9 A, Bienvenu B et al (2009) Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients. Ann Rheum Dis 68:658\u2013663","journal-title":"Ann Rheum Dis"},{"key":"7074_CR17","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1200\/JCO.18.00374","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK et al (2018) Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. J Clin Oncol 36:3043\u20133054","journal-title":"J Clin Oncol"},{"key":"7074_CR18","first-page":"CD009764","volume":"10","author":"SC Herath","year":"2018","unstructured":"Herath SC, Normansell R, Maisey S, Poole P (2018) Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev 10:CD009764","journal-title":"Cochrane Database Syst Rev"},{"key":"7074_CR19","first-page":"CD012406","volume":"3","author":"C Kelly","year":"2018","unstructured":"Kelly C, Chalmers JD, Crossingham I, Relph N, Felix LM, Evans DJ et al (2018) Macrolide antibiotics for bronchiectasis. Cochrane Database Syst Rev 3:CD012406","journal-title":"Cochrane Database Syst Rev"},{"key":"7074_CR20","first-page":"51","volume":"28","author":"M Laudien","year":"2010","unstructured":"Laudien M, Gadola SD, Podschun R, Hedderich J, Paulsen J, Reinhold-Keller E et al (2010) Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polyps. Clin Exp Rheumatol 28:51\u201355","journal-title":"Clin Exp Rheumatol"},{"key":"7074_CR21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/rheumatology\/kex001","volume":"56","author":"A Salmela","year":"2017","unstructured":"Salmela A, Rasmussen N, Tervaert JWC, Jayne DRW, Ekstrand A, European Vasculitis Study Group (2017) Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate. Rheumatology (Oxford) 56:965\u2013972","journal-title":"Rheumatology (Oxford)"},{"key":"7074_CR22","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1093\/rheumatology\/keab267","volume":"60","author":"S Monti","year":"2021","unstructured":"Monti S, Delvino P, Riboli M, Rebuffi C, Xoxi B, De Silvestri A et al (2021) The role of trimethoprim\/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis. Rheumatology (Oxford) 60:3553\u20133564","journal-title":"Rheumatology (Oxford)"},{"key":"7074_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D et al (2018) PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467\u2013473","journal-title":"Ann Intern Med"},{"key":"7074_CR24","doi-asserted-by":"publisher","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","volume":"123","author":"WS Richardson","year":"1995","unstructured":"Richardson WS, Wilson MC, Nishikawa J, Hayward RS (1995) The well-built clinical question: a key to evidence-based decisions. ACP J Club 123:A12\u2013A13","journal-title":"ACP J Club"},{"issue":"Suppl 4","key":"7074_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/2047-783X-14-S4-265","volume":"14","author":"K Zycinska","year":"2009","unstructured":"Zycinska K, Wardyn KA, Zielonka TM, Krupa R, Lukas W (2009) Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement. Eur J Med Res 14(Suppl 4):265\u2013267","journal-title":"Eur J Med Res"},{"key":"7074_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/infdis\/jiy493","volume":"219","author":"D Chanouzas","year":"2019","unstructured":"Chanouzas D, Sagmeister M, Faustini S, Nightingale P, Richter A, Ferro CJ et al (2019) Subclinical reactivation of cytomegalovirus drives CD4+CD28null T-cell expansion and impaired immune response to pneumococcal vaccination in antineutrophil cytoplasmic antibody-associated vasculitis. J Infect Dis 219:234\u2013244","journal-title":"J Infect Dis"},{"key":"7074_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/1756-185x.12022","volume":"16","author":"EG Yegin","year":"2013","unstructured":"Yegin EG, Can M, Yilmaz N, Aydin SZ, Yavuz S, Tuglular S et al (2013) Activity and damage in granulomatosis with polyangiitis. Int J Rheum Dis 16:61\u201371","journal-title":"Int J Rheum Dis"},{"key":"7074_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/rheumatology\/kez236","volume":"59","author":"BK Tan","year":"2020","unstructured":"Tan BK, Crabol Y, Tasse J, Laurent F, Nekkab N, Vinter C et al (2020) No evident association of nasal carriage of Staphylococcus aureus or its small-colony variants with cotrimoxazole use or ANCA-associated vasculitis relapses. Rheumatology (Oxford) 59:77\u201383","journal-title":"Rheumatology (Oxford)"},{"key":"7074_CR29","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.jaut.2019.102397","volume":"108","author":"L Quartuccio","year":"2020","unstructured":"Quartuccio L, Bond M, Isola M, Monti S, Felicetti M, Furini F et al (2020) Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors. J Autoimmun 108:102397","journal-title":"J Autoimmun"},{"key":"7074_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3109\/s10165-011-0525-5","volume":"22","author":"S Ozaki","year":"2012","unstructured":"Ozaki S, Atsumi T, Hayashi T, Ishizu A, Kobayashi S, Kumagai S et al (2012) Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol 22:394\u2013404","journal-title":"Mod Rheumatol"},{"key":"7074_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1445-5994.2007.01382.x","volume":"37","author":"K Meuli","year":"2007","unstructured":"Meuli K, Chapman P, O\u2019Donnell J, Frampton C, Stamp L (2007) Audit of pneumocystis pneumonia in patients seen by the Christchurch Hospital rheumatology service over a 5-year period. Intern Med J 37:687\u2013692","journal-title":"Intern Med J"},{"key":"7074_CR32","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s10067-018-4155-6","volume":"37","author":"EH Matraiah","year":"2018","unstructured":"Matraiah EH, Olisaka N, Philipos M, Walbaum D, Dospinescu P, Fluck N et al (2018) Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis. Clin Rheumatol 37:1991\u20131996","journal-title":"Clin Rheumatol"},{"key":"7074_CR33","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1136\/annrheumdis-2017-212861","volume":"77","author":"A Kronbichler","year":"2018","unstructured":"Kronbichler A, Kerschbaum J, Gopaluni S, Tieu J, Alberici F, Jones RB et al (2018) Trimethoprim-sulfamethoxazole prophylaxis prevents severe\/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 77:1440\u20131447","journal-title":"Ann Rheum Dis"},{"key":"7074_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10157-015-1199-7","volume":"20","author":"K Kitagawa","year":"2016","unstructured":"Kitagawa K, Furuichi K, Sagara A, Shinozaki Y, Kitajima S, Toyama T et al (2016) Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis. Clin Exp Nephrol 20:703\u2013711","journal-title":"Clin Exp Nephrol"},{"issue":"Suppl 111","key":"7074_CR35","first-page":"40","volume":"36","author":"J Fijo\u0142ek","year":"2018","unstructured":"Fijo\u0142ek J, Wiatr E, Petroniec V, Augustynowicz-Kopec E, Bednarek M, Gawryluk D et al (2018) The presence of staphylococcal superantigens in nasal swabs and correlation with activity of granulomatosis with polyangiitis in own material. Clin Exp Rheumatol 36(Suppl 111):40\u201345","journal-title":"Clin Exp Rheumatol"},{"key":"7074_CR36","doi-asserted-by":"publisher","first-page":"e1051","DOI":"10.7717\/peerj.1051","volume":"3","author":"E Besada","year":"2015","unstructured":"Besada E, Koldingsnes W, Nossent JC (2015) Staphylococcus aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis. PeerJ 3:e1051","journal-title":"PeerJ"},{"key":"7074_CR37","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","volume":"77","author":"JW Park","year":"2018","unstructured":"Park JW, Curtis JR, Moon J, Song YW, Kim S, Lee EB (2018) Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Ann Rheum Dis 77:644\u2013649","journal-title":"Ann Rheum Dis"},{"key":"7074_CR38","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/23744235.2019.1648855","volume":"51","author":"CC Lim","year":"2019","unstructured":"Lim CC, Tan BH, Tung YT, Huang H, Hao Y, Mok IYJ et al (2019) Risk-stratified approach to anti-viral prophylaxis against cytomegalovirus disease in glomerulonephritis and renal vasculitis treated with potent immunosuppressants. Infect Dis (Lond) 51:745\u2013752","journal-title":"Infect Dis (Lond)"},{"key":"7074_CR39","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3899\/jrheum.180310","volume":"45","author":"C Garnier","year":"2018","unstructured":"Garnier C, Ribes D, Chauveau D, Huart A, Pugnet G, Adoue D et al (2018) Zoster after cyclophosphamide for systemic lupus erythematosus or vasculitis: incidence, risk factors, and effect of antiviral prophylaxis. J Rheumatol 45:1541\u20131548","journal-title":"J Rheumatol"},{"key":"7074_CR40","unstructured":"KDIGO (2023) KDIGO 2023 ANCA guideline update available for public review. https:\/\/kdigo.org\/kdigo-2023-anca-guideline-update-available-for-public-review\/. Accessed 12 Feb 2024"},{"key":"7074_CR41","unstructured":"PCORnet (2023) Patient-centered outcomes research network. https:\/\/pcornet.org\/.\u00a0Accessed 12 Feb 2024"},{"issue":"24","key":"7074_CR42","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","volume":"328","author":"MA Hern\u00e1n","year":"2022","unstructured":"Hern\u00e1n MA, Wang W (2022) Leaf DE Target trial emulation: a framework for causal inference from observational data. JAMA. 328(24):2446\u20132447. https:\/\/doi.org\/10.1001\/jama.2022.21383","journal-title":"JAMA."}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07074-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07074-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07074-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T09:10:52Z","timestamp":1723885852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07074-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["7074"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07074-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The content is solerly the responsibility of the authors and does not represent the official views of the National Institutes of Health or the Department of Veterans Affairs.\u00a0VKD receives personal fees from Amgen, Pfizer, Bayer, Forma Therapeutics, UpToDate, outside of the submitted work. CTT receives royalties from SAGE Publishing for activities unrelated to the submitted work. JER conducted this work while affiliated with the University of North Carolina and is now employed by GlaxoSmithKline and Viiv Healthcare. MW conducted this work while affiliated with the University of North Carolina and is now employed by Vanderbilt University Medical Center. MHH conducted this work while affiliated with the University of North Carolina and is now employed by Novant Presbyterian Medical Center.\u00a0The other authors have disclosed no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}